Evaluation of the feasibility, safety and efficacy of the use of intravenous infusions of adenosine triphosphate (atp) in people affected by moderate to severe …

A Ruiz, D Sánchez, A Lafuente, G Ortega… - The Journal of …, 2022 - Springer
Background There are currently no drug therapies modifying the natural history of patients
suffering Alzheimer's disease (AD). Most recent clinical trials in the field include only …
被引用次数：1 相关文章

[引用][C] Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe …

A Ruiz, D Sánchez, A Lafuente… - … of Prevention of …, 2022 - produccioncientifica.ucm.es
Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of
Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer’s Disease …

Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe …

A Ruiz, D Sánchez, A Lafuente, G Ortega, M Buendía… - 2022 - pubmed.ncbi.nlm.nih.gov
Background There are currently no drug therapies modifying the natural history of patients
suffering Alzheimer's disease (AD). Most recent clinical trials in the field include only …

Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe …

A Ruiz, D Sanchez, A Lafuente… - JPAD-Journal of …, 2022 - cris.maastrichtuniversity.nl
Background There are currently no drug therapies modifying the natural history of patients
suffering Alzheimer's disease (AD). Most recent clinical trials in the field include only …